Get the Stockscreener App
9.93
0.81%
0.08
After Hours:
9.92
-0.010
-0.10%
Kura Oncology Inc stock is traded at $9.93, with a volume of 1.35M.
It is up +0.81% in the last 24 hours and up +21.25% over the past month.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
See More
Previous Close:
$9.85
Open:
$9.93
24h Volume:
1.35M
Relative Volume:
0.81
Market Cap:
$861.90M
Revenue:
-
Net Income/Loss:
$-168.09M
P/E Ratio:
-4.576
EPS:
-2.17
Net Cash Flow:
$-138.01M
1W Performance:
+1.33%
1M Performance:
+21.25%
6M Performance:
+72.10%
1Y Performance:
-46.56%
1-Day Range:
$9.765
$10.13
1-Week Range:
$9.42
$10.41
52-Week Range:
$5.41
$19.73
Kura Oncology Inc Stock (KURA) Company Profile
Name
Kura Oncology Inc
Sector
Industry
Phone
(858) 500-8800
Address
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Compare KURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
9.93 | 854.95M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | Guggenheim | Neutral |
| Feb-06-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-24-24 | Initiated | UBS | Buy |
| Oct-14-24 | Downgrade | Stifel | Buy → Hold |
| Dec-22-23 | Initiated | Mizuho | Buy |
| Aug-11-23 | Initiated | BofA Securities | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Perform |
| May-17-23 | Initiated | BTIG Research | Buy |
| Jan-31-23 | Initiated | Stifel | Buy |
| Jul-12-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-15-22 | Initiated | Jefferies | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Dec-07-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Nov-05-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Initiated | Credit Suisse | Outperform |
| May-05-20 | Initiated | Barclays | Overweight |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Nov-09-18 | Initiated | Piper Jaffray | Overweight |
| Aug-01-18 | Initiated | H.C. Wainwright | Buy |
| Oct-13-16 | Resumed | Leerink Partners | Outperform |
| Jan-22-16 | Initiated | JMP Securities | Mkt Outperform |
| Dec-30-15 | Initiated | Oppenheimer | Outperform |
| Dec-16-15 | Initiated | Citigroup | Buy |
View All
Kura Oncology Inc Stock (KURA) Latest News
What momentum indicators show for Kura Oncology Inc. stock2025 Institutional Moves & Growth Focused Investment Plans - newser.com
Can technical indicators confirm Kura Oncology Inc.’s reversalJuly 2025 Trade Ideas & AI Based Buy and Sell Signals - newser.com
Visual analytics tools that track Kura Oncology Inc. performanceNew Guidance & Low Risk Entry Point Tips - newser.com
How sustainable is Kura Oncology Inc. stock dividend payoutJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
How Kura Oncology Inc. stock reacts to Fed rate cutsForecast Cut & Free Growth Oriented Trading Recommendations - newser.com
Predicting Kura Oncology Inc. trend using moving averagesMarket Movers & AI Optimized Trading Strategy Guides - newser.com
Can Kura Oncology Inc. stock resist market sell offsWeekly Trade Recap & Daily Profit Maximizing Trade Tips - newser.com
Will Kura's Menin Inhibitor Deliver Where Other AML Therapies Fall Short? - RTTNews
What analysts say about Kura Oncology Inc stockPrice Channel Trading & Small Budget Trading Tips - earlytimes.in
Identifying reversal signals in Kura Oncology Inc.2025 Market Sentiment & Verified Technical Trade Signals - newser.com
Custom strategy builders for tracking Kura Oncology Inc.2025 Trade Ideas & Fast Gain Stock Tips - newser.com
Will Kura Oncology Inc. stock reach all time highs in 2025Exit Point & Weekly Watchlist for Hot Stocks - newser.com
Kura Oncology (NASDAQ:KURA) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Advanced analytics toolkit walkthrough for Kura Oncology Inc.Earnings Beat & High Accuracy Swing Trade Signals - newser.com
Kura Oncology (NASDAQ:KURA) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Kura Oncology Inc. recovery potential after sell offMarket Performance Summary & Verified Technical Signals - newser.com
Menin Inhibitors Drug Market Report 2025: Price, Sales & Clinical Trials Insights 2024-2028 - GlobeNewswire Inc.
How Kura Oncology Inc. stock reacts to bond yieldsEarnings Risk Summary & Free Weekly Watchlist of Top Performers - newser.com
Real time social sentiment graph for Kura Oncology Inc.Weekly Investment Report & Verified Entry Point Signals - newser.com
Kura Oncology (NASDAQ:KURA) Trading 8.9% HigherStill a Buy? - MarketBeat
Wealth Enhancement Advisory Services LLC Buys 35,779 Shares of Kura Oncology, Inc. $KURA - MarketBeat
What drives Kura Oncology Inc stock priceEarnings Growth Projections & High Yield Market Growth - earlytimes.in
Kura Oncology, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
What MACD signals say about Kura Oncology Inc.2025 Technical Patterns & Long-Term Safe Investment Plans - newser.com
Can Kura Oncology Inc. stock withstand economic slowdownJuly 2025 WrapUp & Community Trade Idea Sharing Platform - newser.com
Kura Oncology Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - MarketScreener
Kura Oncology Inc. stock prediction for this week2025 Support & Resistance & Fast Entry Momentum Alerts - newser.com
How Kura Oncology Inc. stock performs in rate cut cyclesWall Street Watch & Low Risk High Reward Ideas - newser.com
Will Kura Oncology Inc. bounce back from current supportGap Up & Smart Investment Allocation Insights - newser.com
Is Kura Oncology Inc a good long term investmentCash Flow Trends & View Live Stock Forecasts Instantly - earlytimes.in
Kura Oncology (KURA) Grants Inducement Awards to New Employees - GuruFocus
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
122,250-Option Grant for New Hires: Kura Oncology Grants Options at $9.20, vesting over four years - Stock Titan
Applying chart zones and confluence areas to Kura Oncology Inc.Earnings Risk Report & High Yield Stock Recommendations - newser.com
Kura Oncology, Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
Kura Oncology at UBS Virtual Oncology Day: Strategic Advances in AML Treatment - Investing.com Canada
Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia - MarketScreener
Kura Oncology (KURA) Advances KOMET-007 Trial with First Patient Dosed - GuruFocus
Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) - The Manila Times
Kura Oncology and Kyowa Kirin Initiate KOMET-007 Trial Evaluating Ziftomenib in Combination with FLT3 Inhibitors for Frontline Treatment of AML - Quiver Quantitative
Kura Oncology stock maintains Market Outperform rating at Citizens JMP By Investing.com - Investing.com Canada
Kura Oncology Inc Stock (KURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):